tiprankstipranks
Trending News
More News >
Actinium Pharmaceuticals (ATNM)
:ATNM
US Market
Advertisement

Actinium Pharmaceuticals (ATNM) Financial Statements

Compare
2,242 Followers

Actinium Pharmaceuticals Financial Overview

Actinium Pharmaceuticals's market cap is currently $49.91M. The company's EPS TTM is $-0.21; its P/E ratio is ―; Actinium Pharmaceuticals is scheduled to report earnings on March 14, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Currency in USD

Actinium Pharmaceuticals Earnings and Revenue History

Actinium Pharmaceuticals Debt to Assets

Actinium Pharmaceuticals Cash Flow

Actinium Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis